82834-12-6 (N-((S)乙氧羰基-1-丁基)-(S)丙氨酸,N-(S)-1-Carbethoxybutyl-(S)-alanine)

CAS号:
82834-12-6
中文名称:
N-((S)乙氧羰基-1-丁基)-(S)丙氨酸
英文名称:
N-(S)-1-Carbethoxybutyl-(S)-alanine
分子式:
C10H19NO4
分子量:
217.26216340065

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)名称与标识符

名称

中文别名:
N-((S)乙氧羰基-1-丁基)-(S)丙氨酸;N-[(S)-乙氧羰基-1-丁基]-(S)-丙氨酸;N-((S)-乙氧羰基-1-丁基)-(S)-丙氨酸;N-[S-乙氧羰基-1-丁基]-S-丙氨酸;N-((S)乙氧羰基-1-丁基)-(S)-丙氨酸;1-苄基-4-(CBZ-氨基)哌啶;N-((S)-乙氧基羰基-1-丁基)-(S)-丙氨酸;N-((S)乙氧羰基-1-丁基)-(S)丙氨;N-[1-(S)-乙氧羰基-丁基]-L-丙氨酸;培哚普利中间体1;培哚普利中间体;N-((S)-乙氧羰基-1-丁基)-(S)丙氨酸;侧链;
英文别名:
(S)-2-(((S)-1-Ethoxy-1-oxopentan-2-yl)amino)propanoic acid;N-((S)-Ethoxycarbonyl-1-butyl)-(S)-Alanine;(2s)-2-(((s)-1-(ethoxycarbonyl)butyl)amino)propanoic acid;N-[(S)-1-Carbethoxybutyl]-(S)-Alanine;N-((S)-1-Ethoxycarbonylbutyl)-L-Alanine;N-((S)Ethoxycarbonylbutyl)-(S)-Alanine;N-((s)-Ethoxycarbonyl)-(s)-alanine;N-((s)-Ethoxycarbonyl)-(s)-alanine-;(S)-N-(Ethoxycarbonyl)butyl-(S)-alanine;N-[(S)-1-CARBETHOXY-1-BUTYL]-(S)-ALANINE( PERINDOPRIL INTERMEDIATE);2-(1-Carboxyethylamino)-pentacoic acid ethyl ester;N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine;N-[(S)-ETHOXYCARBONYLBUTYL]-L-ALANINE;N-[-(S)-Ethoxycarbonylbutyl]-L-alanine;Perindopril Intermediates;intermediate of perindopril;N-((S)Ethoxycarbonylbutyl)-(S)-Alanine (high-pressure hydrogenation);N-[S-Ethoxycarbonyl-1-Butyl]-S-Alanine;N-[(S)-Ethoxycarbonyl-1-Butyl]-(S)-Alanine;(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoic acid;L-Norvaline, N-(1-carboxyethyl)-, 1-ethyl ester, (S)- (ZCI);N-[(1S)-1-Carboxyethyl]-L-norvaline 1-ethyl ester (ACI);AKOS015892676;(S)-2-((S)-1-ethoxy-1-oxopentan-2-ylamino)propanoic acid;(2S)-2-{[(2S)-1-ETHOXY-1-OXOPENTAN-2-YL]AMINO}PROPANOIC ACID;N-((S)-1-carbetoxybutyl)-(S)-alanine;L-Norvaline, N-[(1S)-1-carboxyethyl]-, 1-ethyl ester;AS-70546;N-[(2S)-1-Ethoxy-1-oxopentan-2-yl]-L-alanine;(S)-N-[(S)-1-(ethoxycarbonyl)butyl]alanine;MFCD07782126;n-((s)-1-carbethoxybutyl)-(s)-alanine;HY-20303;N-[(S)-1-Carbethoxy-1-butyl]-L-alanine;DTXSID50434230;N-[1-(S)-ethoxycarbonyl-1-butyl]-(S)-alanine;N-[(S)-Ethoxycarbonylbutyl]-Ala-OH;n-((s)-1-carbethoxy-1-butyl)-(s)-alanine;N-[(2S)-1-Ethoxy-1-oxo-2-pentanyl]-L-alanine;SCHEMBL300278;F14491;AMY3398;((S)-1-ethoxy-1-oxopentan-2-yl)-L-alanine;Q-201439;N-[1-(S)-Ethoxycarbonylbutyl]-(S)-alanine;AUVAVXHAOCLQBF-YUMQZZPRSA-N;N-(1-(S)-Ethoxycarbonylbutyl)-L-alanine;82834-12-6;N-((S)-1-carbethoxybutyl)-L-alanine;CS-0003964;(S)-N-(1-Carboxyethyl)-L-norvaline 1-Ethyl Ester; N-((S)-Ethoxycarbonyl-1-butyl)-(S)-alanine;

标识符

MDL:
MFCD07782126
InChIKey:
AUVAVXHAOCLQBF-YUMQZZPRSA-N
Inchi:
1S/C10H19NO4/c1-4-6-8(10(14)15-5-2)11-7(3)9(12)13/h7-8,11H,4-6H2,1-3H3,(H,12,13)/t7-,8-/m0/s1
SMILES:
[C@H](CCC)(C(=O)OCC)N[C@@H](C)C(=O)O

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)物化性质

实验特性

  • LogP : 1.17180
  • PSA : 75.63000
  • 折射率 : 1.461
  • 沸点 : 324.1 ℃ at 760 mmHg
  • 熔点 : 145-150 ºC
  • 蒸气压 : 0.0±1.5 mmHg at 25°C
  • 闪点 : 149.8±23.7 °C
  • 颜色与性状 : 白色或淡黄色结晶粉末
  • 密度 : 1.1±0.1 g/cm3

计算特性

  • 精确分子量 : 217.13100
  • 氢键供体数量 : 2
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 8
  • 同位素质量 : 217.13140809g/mol
  • 重原子数量 : 15
  • 复杂度 : 218
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 2
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -0.9
  • 拓扑分子极性表面积 : 75.6Ų

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)海关数据

海关编码:
2922509090
海关数据:

中国海关编码:

2922509090

概述:

2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0%

申报要素:

品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装

监管条件:

A.入境货物通关单
B.出境货物通关单

检验检疫类别:

R.进口食品卫生监督检验
S.出口食品卫生监督检验

Summary:

2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)推荐厂家 更多厂家(95)

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)合成路线

合成路线:1 步
反应条件:
参考文献:
[2,3]-Sigmatropic rearrangement of allylic selenimides: Strategy for the synthesis of peptides, peptidomimetics, and N-aryl vinyl glycines
Armstrong, Alan; et al, Journal of Organic Chemistry, 2014, 79(9), 3895-3907
合成路线:1 步
反应条件:
参考文献:
Design, synthesis, and physicochemical properties of a novel, conformationally restricted 2,3-dihydro-1,3,4-thiadiazole-containing angiotensin converting enzyme inhibitor which is preferentially eliminated by the biliary route in rats
Bennion, Colin; et al, Journal of Medicinal Chemistry, 1991, 34(1), 439-47
合成路线:1 步
参考文献:
Preparation of N-alkyl-α-amino acids and their derivatives as intermediates for carboxyalkyl dipeptides
, European Patent Organization, , ,
合成路线:1 步
参考文献:
Preparation of N-[(alkoxycarbonyl)alkyl]-L-alanines as intermediates for carboxyalkyl dipeptides
, European Patent Organization, , ,
合成路线:2 步
反应条件:
参考文献:
[2,3]-Sigmatropic rearrangement of allylic selenimides: Strategy for the synthesis of peptides, peptidomimetics, and N-aryl vinyl glycines
Armstrong, Alan; et al, Journal of Organic Chemistry, 2014, 79(9), 3895-3907
合成路线:2 步
反应条件:
参考文献:
Design, synthesis, and physicochemical properties of a novel, conformationally restricted 2,3-dihydro-1,3,4-thiadiazole-containing angiotensin converting enzyme inhibitor which is preferentially eliminated by the biliary route in rats
Bennion, Colin; et al, Journal of Medicinal Chemistry, 1991, 34(1), 439-47
合成路线:2 步
参考文献:
Preparation of N-[(alkoxycarbonyl)alkyl]-L-alanines as intermediates for carboxyalkyl dipeptides
, European Patent Organization, , ,
合成路线:3 步
反应条件:
参考文献:
[2,3]-Sigmatropic rearrangement of allylic selenimides: Strategy for the synthesis of peptides, peptidomimetics, and N-aryl vinyl glycines
Armstrong, Alan; et al, Journal of Organic Chemistry, 2014, 79(9), 3895-3907
合成路线:1 步
反应条件:
参考文献:
Preparation and enantioseparation of a mixed selector chiral stationary phase derived from benzoylated tartaric acid and 1,2-diphenylethylenediamine
Wei, Wen-Juan; et al, Chirality, 2010, 22(6), 604-611

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)上下游

N-((S)乙氧羰基-1-丁基)-(S)丙氨酸(82834-12-6)参考资料

Reaxys RN:
Beilstein:
N195204
PubChem CID: